nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—type 2 diabetes mellitus—coronary artery disease	0.548	1	CtDrD
Linagliptin—DPP4—Atorvastatin—coronary artery disease	0.11	0.32	CbGbCtD
Linagliptin—ABCB1—Ticagrelor—coronary artery disease	0.0199	0.0578	CbGbCtD
Linagliptin—ABCB1—Clopidogrel—coronary artery disease	0.0123	0.0357	CbGbCtD
Linagliptin—ABCB1—Perindopril—coronary artery disease	0.0123	0.0357	CbGbCtD
Linagliptin—CYP3A4—Ticagrelor—coronary artery disease	0.0119	0.0346	CbGbCtD
Linagliptin—ABCB1—Pitavastatin—coronary artery disease	0.0108	0.0312	CbGbCtD
Linagliptin—ABCB1—Telmisartan—coronary artery disease	0.0108	0.0312	CbGbCtD
Linagliptin—CYP3A4—Fenofibrate—coronary artery disease	0.0106	0.0309	CbGbCtD
Linagliptin—ABCB1—Enalapril—coronary artery disease	0.0102	0.0296	CbGbCtD
Linagliptin—ABCB1—Lisinopril—coronary artery disease	0.0102	0.0296	CbGbCtD
Linagliptin—ABCB1—Timolol—coronary artery disease	0.00867	0.0252	CbGbCtD
Linagliptin—CYP3A4—Gemfibrozil—coronary artery disease	0.0085	0.0247	CbGbCtD
Linagliptin—ABCB1—Ezetimibe—coronary artery disease	0.00793	0.023	CbGbCtD
Linagliptin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00773	0.0224	CbGbCtD
Linagliptin—ABCB1—Captopril—coronary artery disease	0.00763	0.0222	CbGbCtD
Linagliptin—CYP3A4—Clopidogrel—coronary artery disease	0.00737	0.0214	CbGbCtD
Linagliptin—ABCB1—Simvastatin—coronary artery disease	0.00737	0.0214	CbGbCtD
Linagliptin—ABCB1—Pravastatin—coronary artery disease	0.00721	0.0209	CbGbCtD
Linagliptin—ABCB1—Lovastatin—coronary artery disease	0.00721	0.0209	CbGbCtD
Linagliptin—CYP3A4—Eplerenone—coronary artery disease	0.00685	0.0199	CbGbCtD
Linagliptin—ABCB1—Atorvastatin—coronary artery disease	0.00657	0.0191	CbGbCtD
Linagliptin—CYP3A4—Enalapril—coronary artery disease	0.00611	0.0177	CbGbCtD
Linagliptin—ABCB1—Losartan—coronary artery disease	0.00601	0.0174	CbGbCtD
Linagliptin—CYP3A4—Ezetimibe—coronary artery disease	0.00475	0.0138	CbGbCtD
Linagliptin—CYP3A4—Rosuvastatin—coronary artery disease	0.00475	0.0138	CbGbCtD
Linagliptin—CYP3A4—Simvastatin—coronary artery disease	0.00442	0.0128	CbGbCtD
Linagliptin—CYP3A4—Pravastatin—coronary artery disease	0.00432	0.0125	CbGbCtD
Linagliptin—CYP3A4—Lovastatin—coronary artery disease	0.00432	0.0125	CbGbCtD
Linagliptin—CYP3A4—Atorvastatin—coronary artery disease	0.00394	0.0114	CbGbCtD
Linagliptin—CYP3A4—Losartan—coronary artery disease	0.0036	0.0104	CbGbCtD
Linagliptin—Infection—Olmesartan—coronary artery disease	0.000131	0.00142	CcSEcCtD
Linagliptin—Hypersensitivity—Rosuvastatin—coronary artery disease	0.00013	0.00141	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.00013	0.00141	CcSEcCtD
Linagliptin—Cough—Telmisartan—coronary artery disease	0.000129	0.0014	CcSEcCtD
Linagliptin—Constipation—Clopidogrel—coronary artery disease	0.000129	0.0014	CcSEcCtD
Linagliptin—Anaphylactic shock—Niacin—coronary artery disease	0.000129	0.00139	CcSEcCtD
Linagliptin—Skin disorder—Valsartan—coronary artery disease	0.000129	0.00139	CcSEcCtD
Linagliptin—Arthralgia—Trandolapril—coronary artery disease	0.000128	0.00139	CcSEcCtD
Linagliptin—Myalgia—Trandolapril—coronary artery disease	0.000128	0.00139	CcSEcCtD
Linagliptin—Constipation—Lovastatin—coronary artery disease	0.000128	0.00139	CcSEcCtD
Linagliptin—Skin disorder—Olmesartan—coronary artery disease	0.000128	0.00139	CcSEcCtD
Linagliptin—Arthralgia—Enalapril—coronary artery disease	0.000128	0.00138	CcSEcCtD
Linagliptin—Myalgia—Enalapril—coronary artery disease	0.000128	0.00138	CcSEcCtD
Linagliptin—Angioedema—Perindopril—coronary artery disease	0.000128	0.00138	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Simvastatin—coronary artery disease	0.000128	0.00138	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	0.000128	0.00138	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Back pain—Losartan—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Urinary tract infection—Lisinopril—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Rash—Gemfibrozil—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Anaphylactic shock—Pravastatin—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Dermatitis—Gemfibrozil—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000127	0.00137	CcSEcCtD
Linagliptin—Arthralgia—Telmisartan—coronary artery disease	0.000126	0.00137	CcSEcCtD
Linagliptin—Myalgia—Telmisartan—coronary artery disease	0.000126	0.00137	CcSEcCtD
Linagliptin—Headache—Gemfibrozil—coronary artery disease	0.000126	0.00136	CcSEcCtD
Linagliptin—Infection—Pravastatin—coronary artery disease	0.000126	0.00136	CcSEcCtD
Linagliptin—Cough—Captopril—coronary artery disease	0.000126	0.00136	CcSEcCtD
Linagliptin—Constipation—Ezetimibe—coronary artery disease	0.000126	0.00136	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.000125	0.00136	CcSEcCtD
Linagliptin—Skin disorder—Niacin—coronary artery disease	0.000125	0.00135	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000124	0.00135	CcSEcCtD
Linagliptin—Rash—Ticagrelor—coronary artery disease	0.000124	0.00134	CcSEcCtD
Linagliptin—Dermatitis—Ticagrelor—coronary artery disease	0.000124	0.00134	CcSEcCtD
Linagliptin—Headache—Ticagrelor—coronary artery disease	0.000123	0.00133	CcSEcCtD
Linagliptin—Constipation—Eplerenone—coronary artery disease	0.000123	0.00133	CcSEcCtD
Linagliptin—Arthralgia—Captopril—coronary artery disease	0.000123	0.00133	CcSEcCtD
Linagliptin—Myalgia—Captopril—coronary artery disease	0.000123	0.00133	CcSEcCtD
Linagliptin—Anaphylactic shock—Enalapril—coronary artery disease	0.000123	0.00133	CcSEcCtD
Linagliptin—Infection—Trandolapril—coronary artery disease	0.000122	0.00132	CcSEcCtD
Linagliptin—Cough—Perindopril—coronary artery disease	0.000122	0.00132	CcSEcCtD
Linagliptin—Urticaria—Fenofibrate—coronary artery disease	0.000122	0.00132	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000121	0.00131	CcSEcCtD
Linagliptin—Diarrhoea—Rosuvastatin—coronary artery disease	0.000121	0.00131	CcSEcCtD
Linagliptin—Anaphylactic shock—Telmisartan—coronary artery disease	0.000121	0.00131	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Valsartan—coronary artery disease	0.000121	0.00131	CcSEcCtD
Linagliptin—Infection—Telmisartan—coronary artery disease	0.00012	0.0013	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Olmesartan—coronary artery disease	0.00012	0.0013	CcSEcCtD
Linagliptin—Constipation—Simvastatin—coronary artery disease	0.00012	0.0013	CcSEcCtD
Linagliptin—Angioedema—Losartan—coronary artery disease	0.00012	0.0013	CcSEcCtD
Linagliptin—Urticaria—Clopidogrel—coronary artery disease	0.00012	0.0013	CcSEcCtD
Linagliptin—Skin disorder—Trandolapril—coronary artery disease	0.00012	0.00129	CcSEcCtD
Linagliptin—Arthralgia—Perindopril—coronary artery disease	0.000119	0.00129	CcSEcCtD
Linagliptin—Myalgia—Perindopril—coronary artery disease	0.000119	0.00129	CcSEcCtD
Linagliptin—Urticaria—Lovastatin—coronary artery disease	0.000119	0.00129	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000118	0.00128	CcSEcCtD
Linagliptin—Anaphylactic shock—Captopril—coronary artery disease	0.000118	0.00127	CcSEcCtD
Linagliptin—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000118	0.00127	CcSEcCtD
Linagliptin—Skin disorder—Telmisartan—coronary artery disease	0.000117	0.00127	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Niacin—coronary artery disease	0.000117	0.00127	CcSEcCtD
Linagliptin—Urticaria—Ezetimibe—coronary artery disease	0.000117	0.00126	CcSEcCtD
Linagliptin—Immune system disorder—Ramipril—coronary artery disease	0.000117	0.00126	CcSEcCtD
Linagliptin—Mediastinal disorder—Ramipril—coronary artery disease	0.000116	0.00126	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Pravastatin—coronary artery disease	0.000115	0.00125	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000115	0.00124	CcSEcCtD
Linagliptin—Cough—Losartan—coronary artery disease	0.000114	0.00124	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000114	0.00124	CcSEcCtD
Linagliptin—Anaphylactic shock—Perindopril—coronary artery disease	0.000114	0.00124	CcSEcCtD
Linagliptin—Immune system disorder—Timolol—coronary artery disease	0.000114	0.00124	CcSEcCtD
Linagliptin—Mediastinal disorder—Timolol—coronary artery disease	0.000114	0.00123	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000114	0.00123	CcSEcCtD
Linagliptin—Constipation—Valsartan—coronary artery disease	0.000113	0.00123	CcSEcCtD
Linagliptin—Hypersensitivity—Fenofibrate—coronary artery disease	0.000113	0.00122	CcSEcCtD
Linagliptin—Constipation—Olmesartan—coronary artery disease	0.000113	0.00122	CcSEcCtD
Linagliptin—Malnutrition—Ramipril—coronary artery disease	0.000112	0.00122	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000112	0.00121	CcSEcCtD
Linagliptin—Arthralgia—Losartan—coronary artery disease	0.000112	0.00121	CcSEcCtD
Linagliptin—Myalgia—Losartan—coronary artery disease	0.000112	0.00121	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000112	0.00121	CcSEcCtD
Linagliptin—Rash—Rosuvastatin—coronary artery disease	0.000112	0.00121	CcSEcCtD
Linagliptin—Dermatitis—Rosuvastatin—coronary artery disease	0.000111	0.00121	CcSEcCtD
Linagliptin—Urticaria—Simvastatin—coronary artery disease	0.000111	0.00121	CcSEcCtD
Linagliptin—Hypersensitivity—Clopidogrel—coronary artery disease	0.000111	0.0012	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Niacin—coronary artery disease	0.000111	0.0012	CcSEcCtD
Linagliptin—Anaphylactic shock—Furosemide—coronary artery disease	0.000111	0.0012	CcSEcCtD
Linagliptin—Skin disorder—Perindopril—coronary artery disease	0.000111	0.0012	CcSEcCtD
Linagliptin—Headache—Rosuvastatin—coronary artery disease	0.000111	0.0012	CcSEcCtD
Linagliptin—Hypersensitivity—Lovastatin—coronary artery disease	0.00011	0.0012	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.00011	0.00119	CcSEcCtD
Linagliptin—Malnutrition—Timolol—coronary artery disease	0.00011	0.00119	CcSEcCtD
Linagliptin—Constipation—Pravastatin—coronary artery disease	0.000108	0.00117	CcSEcCtD
Linagliptin—Rash—Acetylsalicylic acid—coronary artery disease	0.000108	0.00117	CcSEcCtD
Linagliptin—Hypersensitivity—Ezetimibe—coronary artery disease	0.000108	0.00117	CcSEcCtD
Linagliptin—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000108	0.00117	CcSEcCtD
Linagliptin—Skin disorder—Furosemide—coronary artery disease	0.000108	0.00117	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000107	0.00116	CcSEcCtD
Linagliptin—Anaphylactic shock—Losartan—coronary artery disease	0.000107	0.00116	CcSEcCtD
Linagliptin—Infection—Losartan—coronary artery disease	0.000106	0.00115	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000106	0.00115	CcSEcCtD
Linagliptin—Mediastinal disorder—Lisinopril—coronary artery disease	0.000106	0.00114	CcSEcCtD
Linagliptin—Constipation—Trandolapril—coronary artery disease	0.000105	0.00114	CcSEcCtD
Linagliptin—Urticaria—Valsartan—coronary artery disease	0.000105	0.00114	CcSEcCtD
Linagliptin—Diarrhoea—Fenofibrate—coronary artery disease	0.000105	0.00114	CcSEcCtD
Linagliptin—Constipation—Enalapril—coronary artery disease	0.000105	0.00114	CcSEcCtD
Linagliptin—Urticaria—Olmesartan—coronary artery disease	0.000105	0.00113	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000104	0.00113	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000104	0.00113	CcSEcCtD
Linagliptin—Constipation—Telmisartan—coronary artery disease	0.000103	0.00112	CcSEcCtD
Linagliptin—Hypersensitivity—Simvastatin—coronary artery disease	0.000103	0.00112	CcSEcCtD
Linagliptin—Diarrhoea—Clopidogrel—coronary artery disease	0.000103	0.00112	CcSEcCtD
Linagliptin—Angioedema—Ramipril—coronary artery disease	0.000103	0.00111	CcSEcCtD
Linagliptin—Diarrhoea—Lovastatin—coronary artery disease	0.000103	0.00111	CcSEcCtD
Linagliptin—Urticaria—Niacin—coronary artery disease	0.000102	0.00111	CcSEcCtD
Linagliptin—Malnutrition—Lisinopril—coronary artery disease	0.000102	0.0011	CcSEcCtD
Linagliptin—Urticaria—Pravastatin—coronary artery disease	0.000101	0.00109	CcSEcCtD
Linagliptin—Diarrhoea—Ezetimibe—coronary artery disease	0.000101	0.00109	CcSEcCtD
Linagliptin—Constipation—Captopril—coronary artery disease	0.000101	0.00109	CcSEcCtD
Linagliptin—Angioedema—Timolol—coronary artery disease	0.0001	0.00109	CcSEcCtD
Linagliptin—Back pain—Lisinopril—coronary artery disease	9.87e-05	0.00107	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Perindopril—coronary artery disease	9.86e-05	0.00107	CcSEcCtD
Linagliptin—Diarrhoea—Eplerenone—coronary artery disease	9.84e-05	0.00107	CcSEcCtD
Linagliptin—Cough—Ramipril—coronary artery disease	9.82e-05	0.00106	CcSEcCtD
Linagliptin—Urticaria—Trandolapril—coronary artery disease	9.78e-05	0.00106	CcSEcCtD
Linagliptin—Constipation—Perindopril—coronary artery disease	9.76e-05	0.00106	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Losartan—coronary artery disease	9.76e-05	0.00106	CcSEcCtD
Linagliptin—Hypersensitivity—Valsartan—coronary artery disease	9.75e-05	0.00106	CcSEcCtD
Linagliptin—Urticaria—Enalapril—coronary artery disease	9.74e-05	0.00105	CcSEcCtD
Linagliptin—Rash—Fenofibrate—coronary artery disease	9.68e-05	0.00105	CcSEcCtD
Linagliptin—Dermatitis—Fenofibrate—coronary artery disease	9.67e-05	0.00105	CcSEcCtD
Linagliptin—Headache—Fenofibrate—coronary artery disease	9.62e-05	0.00104	CcSEcCtD
Linagliptin—Urticaria—Telmisartan—coronary artery disease	9.61e-05	0.00104	CcSEcCtD
Linagliptin—Cough—Timolol—coronary artery disease	9.6e-05	0.00104	CcSEcCtD
Linagliptin—Diarrhoea—Simvastatin—coronary artery disease	9.59e-05	0.00104	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Furosemide—coronary artery disease	9.58e-05	0.00104	CcSEcCtD
Linagliptin—Arthralgia—Ramipril—coronary artery disease	9.58e-05	0.00104	CcSEcCtD
Linagliptin—Myalgia—Ramipril—coronary artery disease	9.58e-05	0.00104	CcSEcCtD
Linagliptin—Rash—Clopidogrel—coronary artery disease	9.51e-05	0.00103	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.51e-05	0.00103	CcSEcCtD
Linagliptin—Dermatitis—Clopidogrel—coronary artery disease	9.5e-05	0.00103	CcSEcCtD
Linagliptin—Constipation—Furosemide—coronary artery disease	9.49e-05	0.00103	CcSEcCtD
Linagliptin—Hypersensitivity—Niacin—coronary artery disease	9.48e-05	0.00103	CcSEcCtD
Linagliptin—Headache—Clopidogrel—coronary artery disease	9.45e-05	0.00102	CcSEcCtD
Linagliptin—Rash—Lovastatin—coronary artery disease	9.45e-05	0.00102	CcSEcCtD
Linagliptin—Dermatitis—Lovastatin—coronary artery disease	9.44e-05	0.00102	CcSEcCtD
Linagliptin—Headache—Lovastatin—coronary artery disease	9.39e-05	0.00102	CcSEcCtD
Linagliptin—Arthralgia—Timolol—coronary artery disease	9.36e-05	0.00101	CcSEcCtD
Linagliptin—Myalgia—Timolol—coronary artery disease	9.36e-05	0.00101	CcSEcCtD
Linagliptin—Hypersensitivity—Pravastatin—coronary artery disease	9.34e-05	0.00101	CcSEcCtD
Linagliptin—Angioedema—Lisinopril—coronary artery disease	9.32e-05	0.00101	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.3e-05	0.00101	CcSEcCtD
Linagliptin—Rash—Ezetimibe—coronary artery disease	9.27e-05	0.001	CcSEcCtD
Linagliptin—Dermatitis—Ezetimibe—coronary artery disease	9.26e-05	0.001	CcSEcCtD
Linagliptin—Headache—Ezetimibe—coronary artery disease	9.21e-05	0.000997	CcSEcCtD
Linagliptin—Anaphylactic shock—Ramipril—coronary artery disease	9.18e-05	0.000994	CcSEcCtD
Linagliptin—Constipation—Losartan—coronary artery disease	9.16e-05	0.000991	CcSEcCtD
Linagliptin—Rash—Eplerenone—coronary artery disease	9.07e-05	0.000982	CcSEcCtD
Linagliptin—Urticaria—Perindopril—coronary artery disease	9.07e-05	0.000982	CcSEcCtD
Linagliptin—Hypersensitivity—Trandolapril—coronary artery disease	9.07e-05	0.000982	CcSEcCtD
Linagliptin—Dermatitis—Eplerenone—coronary artery disease	9.06e-05	0.000981	CcSEcCtD
Linagliptin—Diarrhoea—Valsartan—coronary artery disease	9.06e-05	0.000981	CcSEcCtD
Linagliptin—Hypersensitivity—Enalapril—coronary artery disease	9.03e-05	0.000978	CcSEcCtD
Linagliptin—Diarrhoea—Olmesartan—coronary artery disease	9.01e-05	0.000976	CcSEcCtD
Linagliptin—Headache—Eplerenone—coronary artery disease	9.01e-05	0.000976	CcSEcCtD
Linagliptin—Anaphylactic shock—Timolol—coronary artery disease	8.98e-05	0.000972	CcSEcCtD
Linagliptin—Skin disorder—Ramipril—coronary artery disease	8.92e-05	0.000966	CcSEcCtD
Linagliptin—Infection—Timolol—coronary artery disease	8.92e-05	0.000966	CcSEcCtD
Linagliptin—Hypersensitivity—Telmisartan—coronary artery disease	8.91e-05	0.000965	CcSEcCtD
Linagliptin—Cough—Lisinopril—coronary artery disease	8.9e-05	0.000964	CcSEcCtD
Linagliptin—Rash—Simvastatin—coronary artery disease	8.84e-05	0.000957	CcSEcCtD
Linagliptin—Dermatitis—Simvastatin—coronary artery disease	8.83e-05	0.000956	CcSEcCtD
Linagliptin—Urticaria—Furosemide—coronary artery disease	8.82e-05	0.000955	CcSEcCtD
Linagliptin—Diarrhoea—Niacin—coronary artery disease	8.81e-05	0.000954	CcSEcCtD
Linagliptin—Headache—Simvastatin—coronary artery disease	8.78e-05	0.000951	CcSEcCtD
Linagliptin—Skin disorder—Timolol—coronary artery disease	8.72e-05	0.000944	CcSEcCtD
Linagliptin—Arthralgia—Lisinopril—coronary artery disease	8.69e-05	0.000941	CcSEcCtD
Linagliptin—Myalgia—Lisinopril—coronary artery disease	8.69e-05	0.000941	CcSEcCtD
Linagliptin—Diarrhoea—Pravastatin—coronary artery disease	8.67e-05	0.000939	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.63e-05	0.000934	CcSEcCtD
Linagliptin—Urticaria—Losartan—coronary artery disease	8.51e-05	0.000921	CcSEcCtD
Linagliptin—Diarrhoea—Trandolapril—coronary artery disease	8.42e-05	0.000912	CcSEcCtD
Linagliptin—Diarrhoea—Enalapril—coronary artery disease	8.39e-05	0.000908	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.36e-05	0.000906	CcSEcCtD
Linagliptin—Rash—Valsartan—coronary artery disease	8.35e-05	0.000904	CcSEcCtD
Linagliptin—Dermatitis—Valsartan—coronary artery disease	8.34e-05	0.000903	CcSEcCtD
Linagliptin—Anaphylactic shock—Lisinopril—coronary artery disease	8.33e-05	0.000902	CcSEcCtD
Linagliptin—Rash—Olmesartan—coronary artery disease	8.31e-05	0.0009	CcSEcCtD
Linagliptin—Dermatitis—Olmesartan—coronary artery disease	8.3e-05	0.000899	CcSEcCtD
Linagliptin—Headache—Valsartan—coronary artery disease	8.29e-05	0.000898	CcSEcCtD
Linagliptin—Diarrhoea—Telmisartan—coronary artery disease	8.27e-05	0.000896	CcSEcCtD
Linagliptin—Infection—Lisinopril—coronary artery disease	8.27e-05	0.000896	CcSEcCtD
Linagliptin—Headache—Olmesartan—coronary artery disease	8.25e-05	0.000894	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Timolol—coronary artery disease	8.18e-05	0.000885	CcSEcCtD
Linagliptin—Hypersensitivity—Furosemide—coronary artery disease	8.18e-05	0.000885	CcSEcCtD
Linagliptin—Rash—Niacin—coronary artery disease	8.12e-05	0.000879	CcSEcCtD
Linagliptin—Dermatitis—Niacin—coronary artery disease	8.11e-05	0.000878	CcSEcCtD
Linagliptin—Skin disorder—Lisinopril—coronary artery disease	8.09e-05	0.000876	CcSEcCtD
Linagliptin—Headache—Niacin—coronary artery disease	8.06e-05	0.000873	CcSEcCtD
Linagliptin—Diarrhoea—Captopril—coronary artery disease	8.04e-05	0.000871	CcSEcCtD
Linagliptin—Rash—Pravastatin—coronary artery disease	7.99e-05	0.000865	CcSEcCtD
Linagliptin—Dermatitis—Pravastatin—coronary artery disease	7.98e-05	0.000865	CcSEcCtD
Linagliptin—Headache—Pravastatin—coronary artery disease	7.94e-05	0.00086	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Ramipril—coronary artery disease	7.93e-05	0.000858	CcSEcCtD
Linagliptin—Hypersensitivity—Losartan—coronary artery disease	7.89e-05	0.000854	CcSEcCtD
Linagliptin—Constipation—Ramipril—coronary artery disease	7.85e-05	0.00085	CcSEcCtD
Linagliptin—Diarrhoea—Perindopril—coronary artery disease	7.81e-05	0.000846	CcSEcCtD
Linagliptin—Rash—Trandolapril—coronary artery disease	7.76e-05	0.00084	CcSEcCtD
Linagliptin—Dermatitis—Trandolapril—coronary artery disease	7.75e-05	0.00084	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Timolol—coronary artery disease	7.75e-05	0.000839	CcSEcCtD
Linagliptin—Rash—Enalapril—coronary artery disease	7.73e-05	0.000837	CcSEcCtD
Linagliptin—Dermatitis—Enalapril—coronary artery disease	7.72e-05	0.000836	CcSEcCtD
Linagliptin—Headache—Trandolapril—coronary artery disease	7.71e-05	0.000835	CcSEcCtD
Linagliptin—Headache—Enalapril—coronary artery disease	7.68e-05	0.000832	CcSEcCtD
Linagliptin—Rash—Telmisartan—coronary artery disease	7.62e-05	0.000825	CcSEcCtD
Linagliptin—Dermatitis—Telmisartan—coronary artery disease	7.62e-05	0.000825	CcSEcCtD
Linagliptin—Diarrhoea—Furosemide—coronary artery disease	7.59e-05	0.000822	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.59e-05	0.000821	CcSEcCtD
Linagliptin—Headache—Telmisartan—coronary artery disease	7.57e-05	0.00082	CcSEcCtD
Linagliptin—Rash—Captopril—coronary artery disease	7.41e-05	0.000803	CcSEcCtD
Linagliptin—Dermatitis—Captopril—coronary artery disease	7.41e-05	0.000802	CcSEcCtD
Linagliptin—Headache—Captopril—coronary artery disease	7.37e-05	0.000798	CcSEcCtD
Linagliptin—Diarrhoea—Losartan—coronary artery disease	7.33e-05	0.000793	CcSEcCtD
Linagliptin—Urticaria—Ramipril—coronary artery disease	7.29e-05	0.00079	CcSEcCtD
Linagliptin—Rash—Perindopril—coronary artery disease	7.2e-05	0.000779	CcSEcCtD
Linagliptin—Dermatitis—Perindopril—coronary artery disease	7.19e-05	0.000779	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.19e-05	0.000778	CcSEcCtD
Linagliptin—Headache—Perindopril—coronary artery disease	7.15e-05	0.000774	CcSEcCtD
Linagliptin—Urticaria—Timolol—coronary artery disease	7.13e-05	0.000772	CcSEcCtD
Linagliptin—Constipation—Lisinopril—coronary artery disease	7.12e-05	0.000771	CcSEcCtD
Linagliptin—Rash—Furosemide—coronary artery disease	7e-05	0.000758	CcSEcCtD
Linagliptin—Dermatitis—Furosemide—coronary artery disease	6.99e-05	0.000757	CcSEcCtD
Linagliptin—Headache—Furosemide—coronary artery disease	6.95e-05	0.000753	CcSEcCtD
Linagliptin—Hypersensitivity—Ramipril—coronary artery disease	6.76e-05	0.000732	CcSEcCtD
Linagliptin—Rash—Losartan—coronary artery disease	6.75e-05	0.000731	CcSEcCtD
Linagliptin—Dermatitis—Losartan—coronary artery disease	6.74e-05	0.00073	CcSEcCtD
Linagliptin—Headache—Losartan—coronary artery disease	6.71e-05	0.000726	CcSEcCtD
Linagliptin—Urticaria—Lisinopril—coronary artery disease	6.61e-05	0.000716	CcSEcCtD
Linagliptin—Hypersensitivity—Timolol—coronary artery disease	6.61e-05	0.000716	CcSEcCtD
Linagliptin—Diarrhoea—Ramipril—coronary artery disease	6.28e-05	0.00068	CcSEcCtD
Linagliptin—Diarrhoea—Timolol—coronary artery disease	6.14e-05	0.000665	CcSEcCtD
Linagliptin—Hypersensitivity—Lisinopril—coronary artery disease	6.13e-05	0.000664	CcSEcCtD
Linagliptin—Rash—Ramipril—coronary artery disease	5.79e-05	0.000627	CcSEcCtD
Linagliptin—Dermatitis—Ramipril—coronary artery disease	5.78e-05	0.000626	CcSEcCtD
Linagliptin—Headache—Ramipril—coronary artery disease	5.75e-05	0.000623	CcSEcCtD
Linagliptin—Diarrhoea—Lisinopril—coronary artery disease	5.7e-05	0.000617	CcSEcCtD
Linagliptin—Rash—Timolol—coronary artery disease	5.66e-05	0.000613	CcSEcCtD
Linagliptin—Dermatitis—Timolol—coronary artery disease	5.65e-05	0.000612	CcSEcCtD
Linagliptin—Headache—Timolol—coronary artery disease	5.62e-05	0.000609	CcSEcCtD
Linagliptin—Rash—Lisinopril—coronary artery disease	5.25e-05	0.000568	CcSEcCtD
Linagliptin—Dermatitis—Lisinopril—coronary artery disease	5.25e-05	0.000568	CcSEcCtD
Linagliptin—Headache—Lisinopril—coronary artery disease	5.22e-05	0.000565	CcSEcCtD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	1.41e-05	0.000915	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	1.41e-05	0.000915	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—coronary artery disease	1.37e-05	0.00089	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—coronary artery disease	1.35e-05	0.000877	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	1.25e-05	0.000812	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	1.25e-05	0.000812	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—VEGFA—coronary artery disease	1.25e-05	0.00081	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	1.23e-05	0.000802	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.15e-05	0.000749	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.15e-05	0.000749	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HK1—coronary artery disease	1.15e-05	0.000749	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CKM—coronary artery disease	1.15e-05	0.000746	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UQCRFS1—coronary artery disease	1.15e-05	0.000746	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPAP2B—coronary artery disease	1.15e-05	0.000746	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TGFB1—coronary artery disease	1.14e-05	0.000743	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GGT1—coronary artery disease	1.12e-05	0.00073	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—coronary artery disease	1.11e-05	0.00072	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—coronary artery disease	1.09e-05	0.000707	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—coronary artery disease	1.07e-05	0.000694	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PDK4—coronary artery disease	1.07e-05	0.000694	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CKMT2—coronary artery disease	1.07e-05	0.000694	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH6A1—coronary artery disease	1.07e-05	0.000694	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PYGM—coronary artery disease	1.07e-05	0.000694	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SULT4A1—coronary artery disease	1.07e-05	0.000694	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—coronary artery disease	1.06e-05	0.00069	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA5B—coronary artery disease	1.02e-05	0.000663	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	1.01e-05	0.000656	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	9.95e-06	0.000647	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—coronary artery disease	9.78e-06	0.000636	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GK—coronary artery disease	9.51e-06	0.000618	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PFKM—coronary artery disease	9.51e-06	0.000618	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMGCS2—coronary artery disease	9.51e-06	0.000618	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GYG1—coronary artery disease	9.51e-06	0.000618	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LDHA—coronary artery disease	9.51e-06	0.000618	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GATM—coronary artery disease	9.51e-06	0.000618	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—coronary artery disease	9.41e-06	0.000612	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	9.27e-06	0.000603	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—coronary artery disease	9.17e-06	0.000597	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	9.14e-06	0.000595	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AK1—coronary artery disease	9.07e-06	0.00059	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCH1—coronary artery disease	9.07e-06	0.00059	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	8.84e-06	0.000575	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MDH2—coronary artery disease	8.7e-06	0.000566	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPAT—coronary artery disease	8.7e-06	0.000566	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLCD1—coronary artery disease	8.7e-06	0.000566	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UGCG—coronary artery disease	8.7e-06	0.000566	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CKMT1B—coronary artery disease	8.67e-06	0.000564	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—coronary artery disease	8.65e-06	0.000562	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	8.63e-06	0.000561	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CETP—coronary artery disease	8.53e-06	0.000554	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PGM1—coronary artery disease	8.37e-06	0.000544	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—coronary artery disease	8.21e-06	0.000534	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PYGB—coronary artery disease	8.09e-06	0.000526	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CKB—coronary artery disease	8.09e-06	0.000526	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TFRC—coronary artery disease	8.08e-06	0.000526	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	7.8e-06	0.000507	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTM2—coronary artery disease	7.6e-06	0.000494	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLIN1—coronary artery disease	7.6e-06	0.000494	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—COX5B—coronary artery disease	7.6e-06	0.000494	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DLAT—coronary artery disease	7.6e-06	0.000494	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PFKFB3—coronary artery disease	7.6e-06	0.000494	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLAT—coronary artery disease	7.51e-06	0.000489	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	7.24e-06	0.000471	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SULT1E1—coronary artery disease	7.21e-06	0.000469	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPAP2B—coronary artery disease	7.07e-06	0.00046	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	7.07e-06	0.00046	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CKM—coronary artery disease	7.07e-06	0.00046	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	7.05e-06	0.000458	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HK2—coronary artery disease	6.87e-06	0.000447	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKR1B1—coronary artery disease	6.87e-06	0.000447	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC27A1—coronary artery disease	6.59e-06	0.000429	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PYGM—coronary artery disease	6.57e-06	0.000427	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SULT4A1—coronary artery disease	6.57e-06	0.000427	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PDK4—coronary artery disease	6.57e-06	0.000427	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CKMT2—coronary artery disease	6.57e-06	0.000427	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	6.57e-06	0.000427	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—POMC—coronary artery disease	6.55e-06	0.000426	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LCAT—coronary artery disease	6.46e-06	0.00042	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CPT1B—coronary artery disease	6.46e-06	0.00042	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLG—coronary artery disease	6.39e-06	0.000415	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA4—coronary artery disease	6.34e-06	0.000413	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	6.14e-06	0.0004	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PDHA1—coronary artery disease	6.13e-06	0.000398	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCLM—coronary artery disease	6.13e-06	0.000398	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP11B2—coronary artery disease	5.93e-06	0.000386	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TXNRD1—coronary artery disease	5.93e-06	0.000386	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	5.9e-06	0.000383	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GK—coronary artery disease	5.86e-06	0.000381	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PFKM—coronary artery disease	5.86e-06	0.000381	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LDHA—coronary artery disease	5.86e-06	0.000381	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMGCS2—coronary artery disease	5.86e-06	0.000381	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GYG1—coronary artery disease	5.86e-06	0.000381	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GATM—coronary artery disease	5.86e-06	0.000381	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC22A3—coronary artery disease	5.85e-06	0.00038	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ARNTL—coronary artery disease	5.76e-06	0.000375	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HADH—coronary artery disease	5.76e-06	0.000375	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	5.65e-06	0.000367	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	5.64e-06	0.000367	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AK1—coronary artery disease	5.59e-06	0.000363	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCH1—coronary artery disease	5.59e-06	0.000363	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	5.53e-06	0.00036	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G2A—coronary artery disease	5.46e-06	0.000355	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX2—coronary artery disease	5.46e-06	0.000355	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA2—coronary artery disease	5.46e-06	0.000355	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX4—coronary artery disease	5.39e-06	0.000351	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HK1—coronary artery disease	5.39e-06	0.000351	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SULT1A1—coronary artery disease	5.39e-06	0.000351	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG5—coronary artery disease	5.39e-06	0.000351	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLCD1—coronary artery disease	5.36e-06	0.000348	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MDH2—coronary artery disease	5.36e-06	0.000348	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UGCG—coronary artery disease	5.36e-06	0.000348	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPAT—coronary artery disease	5.36e-06	0.000348	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HADHA—coronary artery disease	5.33e-06	0.000347	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA1—coronary artery disease	5.27e-06	0.000343	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	5.27e-06	0.000342	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPA—coronary artery disease	5.21e-06	0.000339	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PGM1—coronary artery disease	5.16e-06	0.000335	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLCB3—coronary artery disease	5.05e-06	0.000328	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA5—coronary artery disease	4.99e-06	0.000325	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PYGB—coronary artery disease	4.98e-06	0.000324	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CKB—coronary artery disease	4.98e-06	0.000324	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—P4HB—coronary artery disease	4.9e-06	0.000319	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G1B—coronary artery disease	4.81e-06	0.000313	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	4.8e-06	0.000312	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.68e-06	0.000305	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.68e-06	0.000305	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—COX5B—coronary artery disease	4.68e-06	0.000305	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.68e-06	0.000305	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DLAT—coronary artery disease	4.68e-06	0.000305	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—VCAN—coronary artery disease	4.53e-06	0.000295	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDOA—coronary artery disease	4.5e-06	0.000292	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.47e-06	0.000291	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SULT1E1—coronary artery disease	4.44e-06	0.000289	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DCN—coronary artery disease	4.37e-06	0.000284	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH2—coronary artery disease	4.25e-06	0.000276	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKR1B1—coronary artery disease	4.24e-06	0.000275	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HK2—coronary artery disease	4.24e-06	0.000275	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HBA1—coronary artery disease	4.14e-06	0.000269	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LIPC—coronary artery disease	4.14e-06	0.000269	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3C2A—coronary artery disease	4.14e-06	0.000269	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2C19—coronary artery disease	4.14e-06	0.000269	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOC3—coronary artery disease	4.11e-06	0.000267	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LDLR—coronary artery disease	4.09e-06	0.000266	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.06e-06	0.000264	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC9A1—coronary artery disease	4.04e-06	0.000263	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTT1—coronary artery disease	4.04e-06	0.000263	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GCLC—coronary artery disease	3.99e-06	0.00026	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CETP—coronary artery disease	3.99e-06	0.00026	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.98e-06	0.000259	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LCAT—coronary artery disease	3.98e-06	0.000259	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SDC1—coronary artery disease	3.95e-06	0.000257	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.92e-06	0.000255	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA4—coronary artery disease	3.91e-06	0.000254	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.78e-06	0.000245	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCLM—coronary artery disease	3.78e-06	0.000245	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PSMA6—coronary artery disease	3.73e-06	0.000243	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PSMB5—coronary artery disease	3.73e-06	0.000243	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.66e-06	0.000238	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.66e-06	0.000238	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CTGF—coronary artery disease	3.64e-06	0.000237	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMGCR—coronary artery disease	3.61e-06	0.000235	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT2—coronary artery disease	3.61e-06	0.000235	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.6e-06	0.000234	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HADH—coronary artery disease	3.55e-06	0.000231	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.55e-06	0.000231	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.54e-06	0.00023	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA2—coronary artery disease	3.36e-06	0.000219	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.36e-06	0.000219	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX2—coronary artery disease	3.36e-06	0.000219	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX4—coronary artery disease	3.32e-06	0.000216	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.32e-06	0.000216	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HK1—coronary artery disease	3.32e-06	0.000216	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.32e-06	0.000216	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLCB1—coronary artery disease	3.32e-06	0.000216	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HADHA—coronary artery disease	3.28e-06	0.000214	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.25e-06	0.000211	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCA1—coronary artery disease	3.22e-06	0.000209	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPA—coronary artery disease	3.21e-06	0.000209	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT1—coronary artery disease	3.12e-06	0.000203	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT1—coronary artery disease	3.12e-06	0.000203	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.11e-06	0.000202	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA5—coronary artery disease	3.08e-06	0.0002	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—P4HB—coronary artery disease	3.02e-06	0.000196	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.96e-06	0.000193	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTP1—coronary artery disease	2.8e-06	0.000182	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—VCAN—coronary artery disease	2.79e-06	0.000182	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.77e-06	0.00018	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.77e-06	0.00018	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—coronary artery disease	2.76e-06	0.00018	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CAT—coronary artery disease	2.72e-06	0.000177	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DCN—coronary artery disease	2.69e-06	0.000175	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOB—coronary artery disease	2.65e-06	0.000172	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.62e-06	0.00017	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTM1—coronary artery disease	2.57e-06	0.000167	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LIPC—coronary artery disease	2.55e-06	0.000166	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HBA1—coronary artery disease	2.55e-06	0.000166	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.55e-06	0.000166	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.55e-06	0.000166	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOC3—coronary artery disease	2.53e-06	0.000165	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPL—coronary artery disease	2.53e-06	0.000164	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LDLR—coronary artery disease	2.52e-06	0.000164	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.49e-06	0.000162	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.49e-06	0.000162	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX1—coronary artery disease	2.46e-06	0.00016	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GCLC—coronary artery disease	2.46e-06	0.00016	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CETP—coronary artery disease	2.46e-06	0.00016	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SDC1—coronary artery disease	2.43e-06	0.000158	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CD36—coronary artery disease	2.4e-06	0.000156	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.37e-06	0.000154	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.3e-06	0.000149	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.3e-06	0.000149	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTHFR—coronary artery disease	2.27e-06	0.000148	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CTGF—coronary artery disease	2.24e-06	0.000146	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT2—coronary artery disease	2.22e-06	0.000145	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.22e-06	0.000145	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AGT—coronary artery disease	2.16e-06	0.000141	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOE—coronary artery disease	2.12e-06	0.000138	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA1—coronary artery disease	2.09e-06	0.000136	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.05e-06	0.000133	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.98e-06	0.000129	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT1—coronary artery disease	1.92e-06	0.000125	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT1—coronary artery disease	1.92e-06	0.000125	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—coronary artery disease	1.84e-06	0.00012	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—POMC—coronary artery disease	1.82e-06	0.000118	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.73e-06	0.000112	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.71e-06	0.000111	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.7e-06	0.000111	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CAT—coronary artery disease	1.68e-06	0.000109	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—coronary artery disease	1.66e-06	0.000108	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOB—coronary artery disease	1.63e-06	0.000106	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—coronary artery disease	1.59e-06	0.000103	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.59e-06	0.000103	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPL—coronary artery disease	1.56e-06	0.000101	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX1—coronary artery disease	1.52e-06	9.87e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CD36—coronary artery disease	1.48e-06	9.61e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.46e-06	9.49e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—coronary artery disease	1.45e-06	9.43e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.4e-06	9.11e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AGT—coronary artery disease	1.33e-06	8.66e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOE—coronary artery disease	1.3e-06	8.48e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA1—coronary artery disease	1.29e-06	8.38e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—coronary artery disease	1.14e-06	7.39e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—POMC—coronary artery disease	1.12e-06	7.29e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—coronary artery disease	1.02e-06	6.64e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—coronary artery disease	9.77e-07	6.35e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—coronary artery disease	8.94e-07	5.81e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CA—coronary artery disease	8.92e-07	5.8e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—coronary artery disease	7.29e-07	4.74e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.5e-07	3.58e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—coronary artery disease	4.49e-07	2.92e-05	CbGpPWpGaD
